Abstract
The in vitro activity of S-25930 and S-25932, two new quinolone antimicrobial agents, against 306 gram-positive organisms representing 12 bacterial species, was evaluated and compared with the activity of ciprofloxacin, difloxacin, enoxacin, amifloxacin and A-56620. Both agents were active against staphylococcal species (including methicillin-resistant and coagulase-negative isolates),Bacillus spp. and group JK diphtheroids. They were less active against streptococcal species andListeria monocytogenes. Their activity against most isolates was superior to that of amifloxacin, enoxacin and difloxacin and similar to that of ciprofloxacin and A-56620.
Similar content being viewed by others
References
Rolston, K. V. I., Ho, D. H., LeBlanc, B., Bodey, G. P. In vitro evaluation of S-25930 and S-25932, two new quinolones against aerobic gram-negative isolates from cancer patients. Antimicrobial Agents and Chemotherapy 1987, 31: 102–103.
Fass, R.J. The quinolones. Annals of Internal Medicine 1985, 102: 400–402.
Rolston, K. V. I., LeBlanc, B., Ho, D. H., Bodey, G. P. In vitro activity of paldimycin (V-70138F) against gram-positive bacteria isolated from patients with cancer. Antimicrobial Agents and Chemotherapy 1987, 31: 650–652.
Kloos, W. E., Schleifer, K. M. Simplified scheme for routine identification of humanStaphylococcus species. Journal of Clinical Microbiology 1975, 1: 82–88.
Kloos, W. E., Wolfschool, J. F. Identification ofStaphylococcus species with the API Staph-Ident system. Journal of Clinical Microbiology 1982, 16: 509–516.
Jones, P. G., Rolston, K. V. I., Fainstein, V., Elting, L., Walters, R. S., Bodey, G. P. Aztreonam therapy in neutropenic patients with cancer. American Journal of Medicine 1986, 81: 243–248.
Facklam, R. R., Carey, R. B. Streptococci and aerococci. In: Lennette, E. M., Balows, A., Hausler, W. J., Shadomy, H. J. (ed.): Manual of clinical microbiology. American Society for Microbiology, Washington, DC, 1985, p. 154–175.
Neu, H. C., Chin, N. In vitro activity of two new quinolone antimicrobial agents, S-25930 and S-25932 compared with that of other agents. Journal of Antimicrobial Chemotherapy 1987, 19: 175–185.
National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, M7-A. Villanova, PA, 1985.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rolston, K.V.I., Ho, D.H., LeBlanc, B. et al. Comparative in vitro activity of the two new 4-quinolones S-25930 and S-25932 against gram-positive bacteria isolated from cancer patients. Eur. J. Clin. Microbiol. Infect. Dis. 7, 681–683 (1988). https://doi.org/10.1007/BF01964254
Issue Date:
DOI: https://doi.org/10.1007/BF01964254